CompletedNot applicableNCT02758054
Official study title

Patient Navigation for Lung Cancer Screening in an Urban Safety-Net System

Study summary

The study proposes to evaluate a patient navigation intervention among a sample of 446 individuals referred for CT-based lung cancer screening in an urban safety-net setting.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedPatient Navigation

The study team can explain what participation involves.

Who it may be forNon-small cell lung cancer (NSCLC)

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 6, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Texas Southwestern Medical Center

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
University of Texas Southwestern Medical Center
Interventions being studied
Behavioral: Patient Navigation
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Patients referred for lung cancer screening using a low-dose CT scan modality who are considered high risk by USPSTF guidelines.
  • Patients who speak English or Spanish
Reasons someone may not be able to joinExclusion criteria
  • Patients who do not speak English or Spanish
  • Patients who are or become ineligible as defined by USPSTF guidelines for lung cancer screening.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - DallasDallas, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 6, 2023. Always confirm current availability with the study team.

View original record ↗